Ricinoleic acid, monosodium salt, (+)-
Common Name: |
Ricinoleic acid, monosodium salt, (+)- |
IUPAC Name: |
null |
Molecular Formula: |
C18H33NaO3 |
SMILES: |
CCCCCCC(C/C=C/CCCCCCCC(=O)O)O.[Na] |
Inchi: |
1S/C18H34O3.Na/c1-2-3-4-11-14-17(19)15-12-9-7-5-6-8-10-13-16-18(20)21;/h9,12,17,19H,2-8,10-11,13-16H2,1H3,(H,20,21);/b12-9+; |
Inchi Key: |
ZCEUYFQZJDGDEF-NBYYMMLRSA-N |
Cas No: |
108321-51-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
1 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
321.45 |
Mass (g/mol) |
321.241 |
Molar Refractivity |
91.10 |
Net Charge |
|
HBD |
2 |
HBA |
3 |
Rt Bonds |
15 |
Rings |
|
TPSA |
57.53 |
Hetero Atoms |
|
Heavy Atoms |
22 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
|
iLOGP |
-5.19 |
XLOGP3 |
6.13 |
WLOGP |
5.08 |
MLOGP |
3.69 |
ESOL Log S |
-4.70 |
ESOL Solubility (mg/ml) |
0.006 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-7.12 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-4.46 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-3.91 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.531 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.234 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |